Yaping Luo

1.6k total citations
81 papers, 1.1k citations indexed

About

Yaping Luo is a scholar working on Oncology, Epidemiology and Molecular Biology. According to data from OpenAlex, Yaping Luo has authored 81 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Oncology, 29 papers in Epidemiology and 17 papers in Molecular Biology. Recurrent topics in Yaping Luo's work include Peptidase Inhibition and Analysis (24 papers), Neuroendocrine Tumor Research Advances (24 papers) and Lymphoma Diagnosis and Treatment (15 papers). Yaping Luo is often cited by papers focused on Peptidase Inhibition and Analysis (24 papers), Neuroendocrine Tumor Research Advances (24 papers) and Lymphoma Diagnosis and Treatment (15 papers). Yaping Luo collaborates with scholars based in China, United States and United Kingdom. Yaping Luo's co-authors include Qingqing Pan, Wen Zhang, Xinxin Cao, Huaxia Yang, Li J, Fang Li, Linyi Peng, Fang Li, Wen Zhang and Fang Li and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Radiology.

In The Last Decade

Yaping Luo

74 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yaping Luo China 17 700 378 302 238 163 81 1.1k
Qingqing Pan China 19 662 0.9× 386 1.0× 242 0.8× 269 1.1× 160 1.0× 70 1.1k
Sabrina Croce France 24 378 0.5× 281 0.7× 285 0.9× 310 1.3× 61 0.4× 97 1.9k
Darcy A. Kerr United States 18 472 0.7× 310 0.8× 127 0.4× 98 0.4× 60 0.4× 113 1.2k
Serkan Kuyumcu Türkiye 18 501 0.7× 218 0.6× 303 1.0× 173 0.7× 377 2.3× 66 1.0k
Gwi Eon Kim South Korea 23 814 1.2× 545 1.4× 163 0.5× 120 0.5× 122 0.7× 64 1.7k
Elia Guadagno Italy 20 284 0.4× 253 0.7× 379 1.3× 132 0.6× 94 0.6× 74 1.1k
Najat Mourra France 23 609 0.9× 570 1.5× 108 0.4× 176 0.7× 86 0.5× 79 1.5k
Sidney P. Kadish United States 14 413 0.6× 859 2.3× 395 1.3× 169 0.7× 85 0.5× 26 1.6k
P.N. Plowman United Kingdom 20 253 0.4× 239 0.6× 194 0.6× 119 0.5× 112 0.7× 55 1.1k
Anita Villani Canada 14 353 0.5× 183 0.5× 107 0.4× 253 1.1× 66 0.4× 46 1.2k

Countries citing papers authored by Yaping Luo

Since Specialization
Citations

This map shows the geographic impact of Yaping Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaping Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaping Luo more than expected).

Fields of papers citing papers by Yaping Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaping Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaping Luo. The network helps show where Yaping Luo may publish in the future.

Co-authorship network of co-authors of Yaping Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Yaping Luo. A scholar is included among the top collaborators of Yaping Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaping Luo. Yaping Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pan, Qingqing, Hui Xu, Shengyu Zhang, et al.. (2025). Head-to-Head Comparison of 68Ga-FAPI-04 and 18F-FDG PET/CT for the Assessment of Crohn’s Disease. Clinical Nuclear Medicine. 50(6). 473–479. 1 indexed citations
2.
Pan, Qingqing, Silu Liu, Jie Feng, et al.. (2025). Glucagon-like peptide-1 receptor PET/CT with 68Ga-exendin-4 for localizing insulinoma: a real-world, single-center study. European Journal of Nuclear Medicine and Molecular Imaging. 52(12). 4487–4496.
3.
Yang, Dan, Ziyue Zhou, Qingqing Pan, et al.. (2025). Comparisons of [68 Ga]Ga-FAPI-04 PET/CT with X-ray imaging in the assessment of patients with rheumatoid arthritis. Clinical Rheumatology. 44(6). 2191–2199.
5.
Yang, Fan, Qingqing Pan, Rui Zhang, et al.. (2024). 68Ga-FAPI and 18F-NaF PET/CT in psoriatic arthritis: a comparative study. Lara D. Veeken. 64(5). 2575–2582. 2 indexed citations
6.
Zhang, Hongzhe & Yaping Luo. (2023). Cardiac Metastasis of Malignant Melanoma Detected by 18F-FDG PET/CT. Diagnostics. 13(13). 2234–2234. 1 indexed citations
7.
Huo, Li, et al.. (2023). Renal Involvement of Immunoglobulin G4–Related Disease Presenting as a Solitary Hypermetabolic Mass Mimicking Renal Tumor on 18F-FDG PET/CT. Clinical Nuclear Medicine. 48(8). e400–e402. 1 indexed citations
8.
Yang, Qiao, Yaping Luo, Yan Zhang, et al.. (2022). Baseline [18F]FDG PET/CT may predict the outcome of newly diagnosed follicular lymphoma in patients managed with initial “watch-and-wait” approach. European Radiology. 32(8). 5568–5576. 6 indexed citations
9.
Pan, Qingqing, Xinxin Cao, Yaping Luo, Li J, & Fang Li. (2021). Semi-quantitative measurements of chemokine receptor 4-targeted 68Ga-pentixafor PET/CT in response assessment of Waldenström macroglobulinemia/lymphoplasmacytic lymphoma. EJNMMI Research. 11(1). 110–110. 8 indexed citations
10.
Ding, Jie, Yushi Zhang, Jin Wen, et al.. (2020). Imaging CXCR4 expression in patients with suspected primary hyperaldosteronism. European Journal of Nuclear Medicine and Molecular Imaging. 47(11). 2656–2665. 59 indexed citations
11.
Luo, Yaping, Ying Zhang, Qingqing Pan, Yan Zhang, & Fang Li. (2020). 18F-FDG PET/computed tomography may predict the outcome of newly diagnosed indolent non-Hodgkin lymphoma in patients managed with initial ‘watch-and-wait’ approach. Nuclear Medicine Communications. 41(12). 1283–1290. 3 indexed citations
12.
Pan, Qingqing, Yaping Luo, Yan Zhang, et al.. (2020). Preliminary evidence of imaging of chemokine receptor-4-targeted PET/CT with [68Ga]pentixafor in non-Hodgkin lymphoma: comparison to [18F]FDG. EJNMMI Research. 10(1). 89–89. 21 indexed citations
13.
Chen, Zhe, et al.. (2020). Diagnosis of bilateral diffuse uveal melanocytic proliferation unveils primary gastric adenocarcinoma: a case report. BMC Ophthalmology. 20(1). 113–113. 4 indexed citations
14.
Qian, Long, et al.. (2019). Prognostic value of interim 18F-FDG PET/CT in T-cell lymphomas. Leukemia & lymphoma. 61(4). 927–933. 4 indexed citations
15.
Luo, Yaping, et al.. (2019). Ectopic insulinoma: case report. BMC Surgery. 19(1). 197–197. 8 indexed citations
16.
Liang, Mei, Jialin Jiang, Hongmei Dai, et al.. (2018). Robotic enucleation for pediatric insulinoma with MEN1 syndrome: a case report and literature review. BMC Surgery. 18(1). 44–44. 17 indexed citations
17.
Luo, Yaping. (2017). Addison disease caused by adrenal tuberculosis: a case report. 37(12). 799–801. 1 indexed citations
18.
Luo, Yaping, Qingqing Pan, & Shaobo Yao. (2017). 68Ga-exendin-4 PET/CT for the localization of insulinomas. 37(3). 137–141.
19.
Luo, Yaping, et al.. (2017). Acinar cell carcinoma of the pancreas presenting as diffuse pancreatic enlargement. Medicine. 96(38). e7904–e7904. 10 indexed citations
20.
Luo, Yaping, et al.. (2014). FDG PET/CT Appearance of Tumor Thrombus of Ovarian Vessels Masquerading as Retroperitoneal Fibrosis. Clinical Nuclear Medicine. 40(6). 501–503. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026